-
-
-
-
Manufacturing
-
Qilu Pharmaceutical launched the first innovative drug in China
Release time：
2023-09-01
On July 12th, 2023, Qilu Pharmaceutical launched the innovative drug Qi Xinke (Iruplinalkib Tablet) in China, this is the first innovative drug launched by Qilu.
Iruplinalkib Tablet is Indicated for the treatment of ALK-positive, locally advanced or metastatic, non-small cell lung cancer (NSCLC) in patients who have disease progression after previous crizotinib treatment or are intolerant to crizotinib.
Related News
0531-83126666 
wangzhan@qilu-pharma.com 
Tel: +86-531-83127705, 83127704, 83127706, 83127711
Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China
E mail：export@qilu-pharma.com, FDF@qilu-pharma.com